Replies to post #168583 on Biotech Values

[genisi]

FDA Approves Genzyme’s Cerdelga™ (eliglustat) Capsules

Only First-Line Oral Therapy Approved for the Treatment of Adults with Gaucher Disease Type 1

http://news.genzyme.com/press-release/fda-approves-genzymes-cerdelga-eliglustat-capsules